Loading…
Based on limited metadata from this FDA Warning Letter to King Bio Inc. issued on March 20, 2019, the company appears to manufacture drug products that did not meet FDA regulatory requirements. Without access to the full letter text or detailed subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata summary.